Gilead Sciences Archives - Page 5 of 7 - Express Pharma

BDR Pharma urges regulators to expedite manufacturing, marketing license process for remdesivir

Dr Reddy’s signs licensing agreement with Gilead Sciences for remdesivir

Zydus Cadila inks licensing pact with Gilead for remdesivir

Remdesivir in India: An unfolding story

Gilead’s remdesivir shows modest improvement in moderate COVID-19 patients

Remdesivir approved for use in treatment of severe COVID-19 patients

Remdesivir has potential to be stockpiled by US federal government’s National Strategic Stockpile for COVID-19

Gilead seeks marketing authorisation from CDSCO for remdesivir

Renewing commitment towards life sciences

Higher dose of Gilead-Galapagos drug meets ulcerative colitis study goals